Mediators of arachidonic acid-induced relaxation of bovine coronary artery

Hypertension

Volumn 28, Issue 1, 1996, Pages 76-82

  Pratt, Phillip F ^b   Rosolowsky, Mark ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

bradykinin; eicosanoids; endothelium; methacholine chloride; muscle, smooth, vascular; nitric oxide

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; ARGININE DERIVATIVE; BRADYKININ; CYCLIC GMP; INDOMETACIN; ISOPRENALINE; METHACHOLINE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CATTLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOSE RESPONSE; DRUG ANTAGONISM; EXTRACTION; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RADIOIMMUNOASSAY;

EID: 0029901719     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.1.76     Document Type: Article

References (33)

1. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res. 1983;53:557-573.
2. Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins. 1976;12:897-913.
3. Dusting GJ, Moncada S, Vane JR. Prostacyclin (PGX) is the endogenous metabolites responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins. 1977;13:3-15.
4. Raz A, Isakson PC, Minkes MS, Needleman P. Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator. J Biol Chem. 1977;252:1123-1126.
5. Furchgott RF, Carvalho MH, Khan MT, Matsunaga K. Evidence for endothelium-dependent vasodilation of resistance vessels by acetylcholine. Blood Vessels. 1987;24:145-149.
6. Lamontagne D, Konig A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol. 1992;20:652-657.
7. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 1987;61:866-879.
8. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
9. Rubanyi GM, Vanhoutte PM. Nature of endothelium-derived relaxing factor: are there two relaxing mediators? Circ Res. 1987;61(suppl II):II-61-II-67.
10. Shikano K, Ohlstein EH, Berkowitz BA. Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle. Br J Pharmacol. 1987;92:483-485.
11. Angus JA, Cocks TM. Endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1989;41:303-351.
12. Rosolowsky M, Campbell WB. Role of PGI2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264:H327-H335.
13. Pfister SL, Campbell WB. Arachidonic acid- and acetylcholine-induced relaxations of rabbit aorta. Hypertension. 1992;20:682-689.
14. Holzmann S. Endothelium-induced relaxation by acetylcholine associated with layer rises in cyclic GMP in coronary arterial strips. J Cyclic Nucl Res. 1982;8:409-419.
15. Beny J, Brunet PC. Neither nitric oxide nor nitroglycerine accounts for all the characteristics of endothelially mediated vasodilation of pig coronary arteries. Blood Vessels. 1988;25:308-311.
16. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988; 153:1251-1256.
17. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vivo and in vitro. Br J Pharmacol. 1990;101:746-752.
18. Peterson DA, Peterson DC, Archer S, Weir EK. The nonspecificity of specific nitric oxide synthase inhibitors. Biochem Biophys Res Commun. 1992;187:797-806.
19. Koller A, Sun D, Messina EJ, Kaley G. L-arginine analogues blunt prostaglandin-related dilation of arterioles. Am J Physiol. 1993;264: 141194-141199.
20. Gmonomethyl L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochem Biophys Res Commun. 1992;188:59.
21. Pinto A, Abraham NG, Mullane KM. Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450 dependent pathway. J Pharmacol Exp Ther. 1987;240:856-863.
22. Katsuki S, Murad F. Regulation of adenosine cyclic 3′,5′-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol. 1977;13:330-341.
23. Revtyak GE, Johnson AR, Campbell WB. Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin. Am J Physiol. 1988;254:C8-C19.
24. Ibe BO, Falck JR, Johnson AR, Campbell WB. Regulation of synthesis of prostacyclin and HETEs in human endothelial cells. Am J Physiol. 1989;256:C1168-C1175.
25. Bell FK, O'Neill JJ, Burgison RM. Determination of the oil/water distribution coefficients of glyceryl trinitrate and two similar nitrate esters. J Pharmacol Sci. 1963;52:637-639.
26. Marietta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988;27:8706-8711.
27. Pratt PF, Nithipatikom K, Campbell WB. Simultaneous determination of nitrate and nitrite in biological samples by multichannel flow injection analysis. Anal Biochem. 1995;231:383-386.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
29. Kalsner S. Cholinergic mechanisms in human coronary artery preparations: implications of species differences. J Physiol. 1985; 358:509-526.
30. Toda N. Isolated human coronary arteries in response to vasoconstrictor substances. Am J Physiol. 1983;245:H937-H941.
31. Förstermann U, Mugge A, Alheid U, Haverich A, Frolich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res. 1988;62:185-190.
32. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ. Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. J Pharmacol Exp Ther. 1986;236:30-36.
33. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther. 1986;237:893-900.